Publication for MAGEH1 and MAGEE1
| Species | Symbol | Function* | Entrez Gene ID* | Other ID | Gene coexpression |
CoexViewer |
|---|---|---|---|---|---|---|
| hsa | MAGEH1 | MAGE family member H1 | 28986 | [link] | ||
| hsa | MAGEE1 | MAGE family member E1 | 57692 |
| Pubmed ID | Priority | Text |
|---|---|---|
| 31516568 | 0.96 | MAGEE1, (H) MAGEH1 and (I) MAGEL2 for patients with the luminal B breast cancer subtype (n=1,425). |
| 0.77 | MAGEE1 (HR, 0.35; 95% CI, 0.12-1.02; P=0.0435) and MAGEH1 (HR, 0.52; 95% CI, 0.30-0.88; P=0.0140) in grade I breast cancer; MAGEA8 (HR, 0.74; 95% CI, 0.57-0.96; P=0.0248) and MAGEC3 (HR, 0.74; 95% CI, 0.57-0.96; P=0.0210) in grade II breast cancer; and MAGEA8 (HR, 0.78; 95% CI, 0.61-0.99; P=0.0373) in grade III breast cancer were significantly associated with improved RFS. | |
| 0.72 | MAGEE1, (G) MAGEF1, (H) MAGEH1 and (I) MAGEL2 for patients with the luminal A breast cancer subtype (n=2,504). | |
| 27852984 | 0.96 | MAGEE1), NP_444436 (mouse Magee2), NP_619648 (human MAGEE2), NP_076277 (mouse Mageh1), NP_054780 (human MAGEH1). |
| 22052522 | 0.94 | MAGEE1, MAGEH1) had female-specific expression following IS. |
The preparation time of this page was 0.0 [sec].
